Today’s top gainers include the company Merck & Co. Inc. (NYSE:MRK) which is in the industry Drug Manufacturers – Major, gaining 0.17% today. In the last week its performance is 1.48%, and 6.53% for the past quarter. Currently, Merck & Co. Inc., MRK has a target price of 61.45, so today’s gain of 0.17% is a significant step towards its target price. The GAP today is therefore 0.54%.
Merck & Co. Inc. (NYSE:MRK), has a market cap of 165469.1, and is based in USA. Insider ownership is at 0.04%, and institutional ownership is 74.80%.
At the current price of 59.65, it has a dividend yield of 3.08%, and its target price is 61.45. This is with a profit margin of 11.70%, and total debt/equity of 0.59. Merck & Co. Inc. (NYSE:MRK) has a P/E of 36.48, as well as a forward P/E of 15.89.
With a current EPS of 1.64, and a forecasted EPS growth for next year at 1.05%,Merck & Co. Inc. (NYSE:MRK) has had a EPS growth for the past five years at 41.50%. For the next five years EPS growth is projected to be 3.35%.
Performance for the year is 6.00%. Since its IPO date on 1/2/1970, the total performance to date is 14.85%.
Volume today for Merck & Co. Inc. (NYSE:MRK), is 7342500, while its average volume is 8912.19. Whilst the total gain today was 0.17%, it did have a day high of -0.50%.
Volatility for this week has been at 1.00%, and 1.40% for the month. The 52-week low for Merck & Co. Inc., MRK has been 35.07%, while the 52-week-high has reached -0.50%.
Looking at its return of investments, which is 6.40%, and its return on assets is 4.60%. Merck & Co. Inc. (NYSE:MRK) has an operating margin of 18.20%. With a sales growth of -1.20% quarter over quarter. Bearing in mind that Merck & Co. Inc., MRK is in the sector Healthcare, its long-term debt/equity is 0.54, and has a current ratio of 1.6 and 1.3 for quick ratio.
So what is the value of Merck & Co. Inc.? Well its PEG is 10.89, and the P/S is 4.2, along with a P/B of 3.78. Meanwhile it has a p/cash of 12.78.